{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:04:40Z","timestamp":1770897880610,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T00:00:00Z","timestamp":1369872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00415-013-6965-4","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T13:01:58Z","timestamp":1369832518000},"page":"1919-1921","source":"Crossref","is-referenced-by-count":21,"title":["Natalizumab and the development of extensive brain lesions in neuromyelitis optica"],"prefix":"10.1007","volume":"260","author":[{"given":"Maciej","family":"Jury\u0144czyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Zaleski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Selmaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,30]]},"reference":[{"key":"6965_CR1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","volume":"80","author":"L Matthews","year":"2013","unstructured":"Matthews L, Marasco R, Jenkinson M et al (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 80:1330\u20131337","journal-title":"Neurology"},{"key":"6965_CR2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1468-1331.2011.03565.x","volume":"19","author":"JA Cabrera-Gomez","year":"2012","unstructured":"Cabrera-Gomez JA, Kister I (2012) Conventional brain MRI in neuromyelitis optica. Eur J Neurol 19:812\u2013819","journal-title":"Eur J Neurol"},{"key":"6965_CR3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/WNL.0b013e31826845fe","volume":"79","author":"A Jacob","year":"2012","unstructured":"Jacob A, Hutchinson M, Elsone L et al (2012) Does natalizumab therapy worsen neuromyelitis optica? Neurology 79:1065\u20131066","journal-title":"Neurology"},{"key":"6965_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","volume":"69","author":"I Kleiter","year":"2012","unstructured":"Kleiter I, Hellwig K, Berthele A et al (2012) Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 69:239\u2013245","journal-title":"Arch Neurol"},{"key":"6965_CR5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1352458511421185","volume":"18","author":"M Barnett","year":"2012","unstructured":"Barnett M, Prineas J, Buckland M, Parratt JD, Pollard JD (2012) Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler 18:108\u2013112","journal-title":"Mult Scler"},{"key":"6965_CR6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(09)70021-3","volume":"8","author":"E Havrdova","year":"2009","unstructured":"Havrdova E, Galetta S, Hutchinson M et al (2009) Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab safety and efficacy in relapsing-remitting multiple sclerosis (AFFIRM) study. Lancet Neurol 8:254\u2013260","journal-title":"Lancet Neurol"},{"key":"6965_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2010.12.001","volume":"302","author":"JE Kim","year":"2011","unstructured":"Kim JE, Kim SM, Ahn SW et al (2011) Brain abnormalities in NMO. J Neurol Sci 302:43\u201348","journal-title":"J Neurol Sci"},{"key":"6965_CR8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","volume":"72","author":"SM Maga\u00f1a","year":"2009","unstructured":"Maga\u00f1a SM, Matiello M, Pittock SJ et al (2009) Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72:712\u2013717","journal-title":"Neurology"},{"key":"6965_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1352458512448268","volume":"19","author":"BF D\u00e9card","year":"2013","unstructured":"D\u00e9card BF, Haghikia A, T\u00f6nnes C, Th\u00f6ne J, Lukas C, Chan A, Gold R (2013) Natalizumab\u2013associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy. Mult Scler 19:249\u2013251","journal-title":"Mult Scler"},{"key":"6965_CR10","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1212\/WNL.0b013e3181a8266f","volume":"72","author":"P Kivis\u00e4kk","year":"2009","unstructured":"Kivis\u00e4kk P, Healy BC, Viglietta V et al (2009) Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology 72:1922\u20131930","journal-title":"Neurology"},{"key":"6965_CR11","doi-asserted-by":"crossref","first-page":"e47578","DOI":"10.1371\/journal.pone.0047578","volume":"7","author":"L B\u00f6rnsen","year":"2012","unstructured":"B\u00f6rnsen L, Christensen JR, Ratzer R et al (2012) Effect of natalizumab on circulating CD4+ T cells in multiple sclerosis. PLoS One 7:e47578","journal-title":"PLoS One"},{"key":"6965_CR12","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/01.wnl.0000327671.91357.96","volume":"71","author":"M Krumbholz","year":"2008","unstructured":"Krumbholz M, Meinl I, K\u00fcmpfel T, Hohlfeld R, Meinl E (2008) Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 71:1350\u20131354","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-6965-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6965-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:23:14Z","timestamp":1559071394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-6965-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,30]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["6965"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-6965-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,30]]}}}